Northfield Laboratories files $100 million shelf

By Ted A. Knutson

Washington, Dec. 23 - Northfield Laboratories Inc. registered a $100 million shelf in an S-3 filing with the Securities and Exchange Commission.

Debt securities, common stock, stock purchase contracts, depositary shares and warrants are specifically included in the shelf, which also allows for convertibles.

The Evanston, Ill.-based pharmaceutical firm said proceeds from offerings authorized by the shelf will be used to fund clinical trial activities and to prepare and submit a biologic license application with the Food and Drug Administration, to prepare for the commercial launch of PolyHeme, for business operations and for other general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.